[Markers of endothelial dysfunction (VCAM-1 and vWF) in chronic hepatitis C]

Insights

Endothelial dysfunction markers, soluble vascular adhesion molecule 1 (sVCAM-1) and von Willebrand factor (vWF:Ag), are elevated in chronic hepatitis C (CHC) patients. These levels correlate with hepatitis activity and significantly with advanced liver fibrosis, indicating their role in CHC pathogenesis.

Area of Science:

  • Hepatology and Viral Hepatitis Research
  • Endothelial Biology and Vascular Function
  • Biomarker Discovery in Liver Disease

Context:

  • Chronic hepatitis C (CHC) is a significant global health concern.
  • Endothelial dysfunction is increasingly recognized in chronic liver diseases.
  • Accurate assessment of liver fibrosis and activity is crucial for patient management.

Purpose:

  • To investigate the association between blood levels of endothelial factors (sVCAM-1 and vWF:Ag) and the biochemical, histological, and virological characteristics of CHC.
  • To determine if these endothelial markers correlate with the severity of liver fibrosis and disease activity in CHC patients.

Summary:

  • This study measured serum levels of sVCAM-1 and vWF:Ag in 69 asymptomatic CHC patients.
  • Elevated levels of sVCAM-1 and/or vWF:Ag were observed in 33.3% of patients.
  • Significantly higher sVCAM-1 levels were found in patients with higher alanine aminotransferase activity and severe liver fibrosis (F3-F4).
  • vWF:Ag levels were also significantly higher in patients with severe liver fibrosis (F3-F4) compared to those with milder fibrosis (F0-F2).

Impact:

  • The findings suggest that elevated sVCAM-1 and vWF:Ag levels are linked to hepatitis activity and, more strongly, to the degree of liver fibrosis in CHC.
  • These endothelial markers may serve as indicators of endothelial dysfunction in the pathogenesis of chronic HCV infection.
  • This research contributes to understanding the role of vascular changes in the progression of CHC and may inform future diagnostic or therapeutic strategies.
Abstract

Related Concept Videos

Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
42
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
765
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
86